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Abstract
Background: Insulin resistance, which can lead to a number of diseases including type 2 diabetes
and coronary heart disease, is believed to have evolved as an adaptation to periodic starvation. The
"thrifty gene" and "thrifty phenotype" hypotheses constitute the dominant paradigm for over four
decades. With an increasing understanding of the diverse effects of impairment of the insulin
signaling pathway, the existing hypotheses are proving inadequate.
Presentation of the hypothesis: We propose a hypothesis that insulin resistance is a socio-
ecological adaptation that mediates two phenotypic transitions, (i) a transition in reproductive
strategy from "r" (large number of offspring with little investment in each) to "K" (smaller number
of offspring with more investment in each) and (ii) a transition from "stronger to smarter" or
"soldier to diplomat" i.e. from relatively more muscle dependent to brain dependent lifestyle. A
common switch could have evolved for the two transitions since the appropriate environmental
conditions for the two transitions are highly overlapping and interacting.
Testing the hypothesis: Gestational insulin resistance diverts more energy through the placenta,
resulting in increased investment per offspring. On the other hand, insulin resistance is associated
with reduced ovulation. The insulin signaling pathway is also related to longevity. Insulin resistance
diverts more nutrients to the brain as compared to muscle. Also, hyperinsulinemia has direct
positive effects on cognitive functions of the brain. The hypothesis gets support from known
patterns in human clinical data and recent research on the molecular interactions in the insulin
signaling pathway. Further we state many predictions of the hypothesis that can be tested
experimentally or epidemiologically.
Implications of the hypothesis: The hypothesis can bring about a significant change in the line
of treatment as well as public health policies for the control of metabolic syndrome.
Background
The Insulin Resistance Syndrome (IRS), also called meta-
bolic syndrome or syndrome X, consists of a cluster of
conditions including hyperinsulinemia, insulin resist-
ance, impaired glucose tolerance, type 2 diabetes, hyper-
tension, atherosclerotic vascular disease and coronary
artery disease [1,2]. Insulin resistance is a condition in
which tissues exhibit reduced response to insulin. This is
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hyperinsulinemia which is thought to be a compensatory
response to reduced insulin sensitivity. A preliminary
diagnostic criterion for insulin resistance is high levels of
plasma insulin in relation to glucose levels. It is believed
that the ability of the pancreatic beta cells to meet the
demand posed by progressive insulin resistance ulti-
mately reaches its limits. The failure of beta cells to secrete
sufficient quantities of insulin leads to type 2 diabetes [3].
Obesity is positively correlated with insulin resistance and
IRS is one of the major causes of mortality in the modern
world.
Over four decades ago, James Neel speculated that the ten-
dency to develop insulin resistance is unlikely to be a
genetic disorder [4]. Instead, it must have evolved as an
adaptive trait that later turned pathological due to
changed life style and diet. He hypothesized that a
"thrifty" genotype that helped survival in primitive life
characterized by periods of "feast and famine" has now
turned detrimental in the modern urban lifestyle and diet.
Neel's hypothesis and its modified versions have domi-
nated thought about the etiology of recent epidemic of
diabetes.
Inadequacies of the thriftiness hypotheses
The thriftiness family of hypotheses believes that the
thrifty tendency minimizes energy loss and facilitates effi-
cient energy storage in the form of fat during the days of
"feast" and helps survival during a subsequent "famine".
However, under conditions of stable and ample food sup-
ply that is characteristic of modern urban life, this ten-
dency leads to obesity and related disorders. A
presumption in Neel's original hypothesis was that a
"quick insulin trigger" after meals helps conserve energy
[4]. For this hypothesis to work it is necessary that the tis-
sues respond to the increased levels of insulin by
increased uptake of glucose. However, it was revealed a
few years later that unlike Neel's presumption, loss of
insulin sensitivity of tissues or insulin resistance is central
to the syndrome [1,2] and therefore Neel's "quick insulin
trigger" does not adequately explain the mechanism of
energy conservation. Despite this failure, Neel's original
thought of "thriftiness" remained dominant albeit with a
modified meaning. In the new interpretation insulin
resistance was thought to take the role of quick insulin
trigger and serve the same purpose.
Later the genetic nature of the thrifty tendency was ques-
tioned [5] and a "thrifty phenotype" hypothesis stemmed
from the finding that low birth weights predict the devel-
opment of diabetes later in life [6]. A strong association
between low birth weight and increased risk of diabetes
and associated disorders has been found across a large
number of geographical areas and ethnic groups through-
out the globe [7-13]. The thrifty phenotype hypothesis
differs from the thrifty gene hypothesis in that it does not
assume the predisposing factors to be genetic but pro-
grammed by the intrauterine environment. According to
the hypothesis, intrauterine undernourished environment
induces thrifty mechanisms because it predicts a future of
starvation. The thriftiness family of hypotheses has domi-
nated evolutionary thought for over four decades. How-
ever, the validity of these hypotheses was never rigorously
tested, mainly because researchers in this field have been
primarily interested in medicine and epidemiology more
than the basic evolutionary biology. When viewed criti-
cally a number of inherent weaknesses in these hypothe-
ses become apparent.
1. The association between obesity and insulin resistance
is very strong and universal, but the direction of the arrow
of causation has been a source of ambiguity. The thrifty
hypotheses presume that the function of the thrifty gene
is to promote fat accumulation [14]. Neel (1962) wrote,
"... the overweight individual of 40 or 50 with mild diabe-
tes is not so much diabetic because he is obese, as he is
obese because he is of a particular (diabetic) genotype"
[4]. The key question is: can we equate the diabetic ten-
dency to thirftiness? Is insulin resistance the thrifty gene
(or phenotype)? Evidence for this is contradictory and
inconsistent. In Pima Indians the most insulin sensitive
individuals had a greater tendency towards weight gain
than the most insulin resistant ones [15] and low insulin
levels were better predictors of weight gain [16]. Hyperin-
sulinemia accompanying insulin resistance can possibly
arrest weight gain rather than promote it by increased
sympathetic nervous system activity and postprandial
thermogenesis [17]. Mice with fat specific disruption of
the insulin receptor have reduced obesity [18]. Insulin
resistance induced by Klotho gene over-expression is
accompanied by reduced adiposity [19]. Contradicting
this, other mechanisms have been suggested by which
insulin resistance may facilitate fat storage. Insulin exerts
an antilipolytic effect in adipocytes and presumably this
effect is relatively preserved in otherwise insulin resistant
state [20]. Loss of neuronal insulin-leptin signaling can
stimulate weight gain, but this is mainly through hyper-
phagia rather than metabolic frugality [3]. The basic tenet
of the thriftiness hypothesis that insulin resistance con-
tributes to a thrifty metabolism leading to energy storage
is not unanimously supported. A number of molecular
mechanisms are now known by which adipocytes actively
modulate insulin resistance [20-23]. Surgical removal of
fat reverses insulin resistance rapidly [24]. Weight loss can
prevent progression from impaired glucose tolerance to
type 2 diabetes [25]. The prevalence of obesity and IRS
have rapidly increased and it is more logical to assume
that increased obesity owing to increased energy intake
[26] has resulted into increase in insulin resistance. OnPage 2 of 13
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responsible for insulin resistance have increased owing to
some unknown reason leading to increase in obesity.
Thus although there might be a positive feedback cycle
between adiposity and insulin resistance, the arrow of
causation seems to be more strongly from adipocity to
insulin resistance.
2. Implicit in the word thrifty is the concept of increased
metabolic efficiency which would facilitate energy saving
and storage. The prediction of the thrifty phenotype
hypothesis is that muscle tissues of people with low birth
weight should have a lower resting rate of metabolism.
Evidence for this is contradictory. Lower resting metabolic
rate was found to be associated with low birth rate in a
small sample [27], whereas measurements on a larger
sample size showed the opposite trend [28]. Therefore the
assumption that low birth weight gives rise to thriftiness
is not unanimously empirically supported.
3. The colder climates with harsh winters must have pro-
vided an ideal "feast and famine" situation of the thrifty
gene hypothesis throughout major part of human evolu-
tion. In such climates hunting-gathering or agriculture is
possible only for a few months of the year and for the rest
survival depends upon stored food. Therefore insulin
resistance should be more common in races that evolved
in highly seasonal environments. Although it is difficult
to correct for dietary and cultural differences in a cross-
cultural study, the gross pattern emerging from the exist-
ing epidemiological data do not support this prediction of
the thrifty gene hypotheses. Upon urbanization, the inci-
dence of IRS in ethnic groups of tropical origins is the
highest, and gradually reduces in people from harsh win-
ter habitats. The European whites have a substantially
lower incidence [16,29] and Iceland has a particularly low
and stable incidence [30]. Eskimos have low incidence
[31]. Urbanized Asians have a very high prevalence [32]
but within urbanized Asians, Japanese have lower preva-
lence [33]. Within the Indian subcontinent, the migrant
Tibetans that came from a harsh cold climate into tropical
peninsula have a lower tendency for central obesity than
the peninsular Indians [34]. The urbanized people of
Kashmir-Himalayas also have a lower prevalence of diabe-
tes than the rest of the urban Indians [35]. It seems a gen-
eral norm that people adapted to harsh winter
environments for several generations have lower tenden-
cies to develop insulin resistance. This is contrary to the
expectation of the thrifty gene hypothesis.
4. O'Rahilly and Farooqi [36] recently reviewed the mode
of action of all known genes predisposing to obesity and
concluded that human obesity was less metabolic and
more neuro-behavioral disorder. Genetic and molecular
differences between obese and non-obese rats also
revealed that the major differences are neuro-behavioral
rather than metabolic [37]. The relative contributions of
metabolic thriftiness and neuro-behavioral factors to the
current obesity epidemic are not yet critically evaluated.
5. In recent years our understanding of the molecular
basis of insulin action and the insulin signaling pathway
has expanded dramatically. We now know that insulin
signaling is not only involved in energy homeostasis but
also in longevity, reproduction, immunity as well as brain
development and function. Insulin resistance is shown to
alter reproduction, immunity and brain function. The
thriftiness family of hypotheses has not provided ade-
quate adaptive explanations for these aspects of insulin
signaling and insulin resistance. For example castration in
male rats induces insulin resistance and obesity [38,39]
and the existing evolutionary paradigm offers no adaptive
explanation for this. Therefore the thrifty gene and thrifty
phenotype hypotheses are certainly inadequate if not
wrong.
Presentation of the hypothesis
Apart from thriftiness by fat storage and utilization, other
mechanisms by which insulin resistance can aid survival
under specific conditions have been suggested. Different
tissues differ in their dependence on insulin for glucose
uptake, skeletal muscles, liver, fat cells and abdominal vis-
cera being among the most insulin dependent and brain,
red blood cells and placenta being among the most insu-
lin independent ones. By varying the levels of insulin and
the degree of insulin sensitivity of tissues the energy
budget allocation to different organs can be finely manip-
ulated. Insulin metabolism is likely to have evolved pri-
marily as a mechanism of differential energy allocation to
different tissues. High insulin resistance or a low level of
insulin would divert more energy to the insulin independ-
ent tissues and less to insulin dependent tissues [16].
Reaven [1] suggested that under conditions of starvation,
insulin resistance makes more glucose available to the
brain.
With the presumption of a role of insulin metabolism in
differential allocation of energy, we develop a hypothesis
that insulin resistance evolved as a socio-ecological and
socio-nutritional adaptation rather than thriftiness. We
agree with the component of Neel's hypothesis that traits
that were adaptive in primitive life are turning detrimental
today, but differ in explaining what was adaptive and why
it is detrimental today. We propose that insulin resistance
can alter the behavioral and reproductive strategies of an
individual. This is achieved on the one hand by modifying
the energy budget allocation to tissues and on the other by
the direct action of insulin on different tissues. We pro-
pose that insulin resistance can bring about two pheno-
typic transitions that we call "r to K strategist" andPage 3 of 13
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explains almost all the physiological findings and epide-
miological patterns that are not explained by the thrifti-
ness hypotheses.
The r to K transition in reproductive strategies
Population biology and evolutionary theory has exten-
sively used the logistic model of population growth and r
and K are the two parameters of the model. The intrinsic
growth rate of a species is denoted by r; and K stands for
the carrying capacity of the environment for the species
[40,41]. The r and K strategies are classically described as
two alternative ways of gaining evolutionary fitness. An r
strategist is one that reproduces faster by producing a large
number of offspring, investing little in each. A K strategist
on the other hand produces fewer offspring but invests
more in each [40-43]. Initially the concept was used across
species but it was shown that this plurality in reproductive
strategies can exist within a species as well [42,44]. Natu-
ral selection would favor an r strategist when there are
ample opportunities for population expansion and
intraspecific competition is minimum. The K strategy will
be favored when the population is close to the carrying
capacity of the environment resulting into fewer opportu-
nities for survival [42,43]. Evolving in an environment
that fluctuates in its selective forces, it would be highly
adaptive to be able to switch between alternative repro-
ductive strategies by a physiological or behavioral switch
[44]. Insulin signaling can provide such a switch. Placenta
is an insulin independent organ and therefore gestational
insulin resistance is expected to divert more nutrients
through the placenta. Maternal insulin resistance is
known to result into larger babies [4,45]. The larger birth
weights do not simply reflect weight gain by mothers. Cat-
alano et al [46] demonstrated that in normal mothers the
fetal weight gain was positively correlated with maternal
weight gain, but in diabetic mothers increase in fetal
weight was independent of maternal weight gain. We
hypothesize therefore that insulin resistance is the mech-
anism by which the investment in a fetus is increased. On
the other hand insulin resistance is also known to reduce
ovulation [47-50]. Insulin resistance is a strong contribu-
tor to polycystic ovarian syndrome (PCOS) and insulin-
sensitizing drugs are the most effective agents to reverse
anovulation due to PCOS [51-53]. Insulin signaling is
involved in reproduction by direct endocrine as well as
neuronal action [52]. Although some important links in
the mechanism are not completely understood, the duel
action of insulin resistance i. e. reducing fertility on the
one hand and increasing fetal growth on the other is well
supported.
The r and K selection strategies in reproduction are also
accompanied by differences in lifespan. The r strategists
are typically short lived and K strategists long lived. In
mammals body size and longevity correlate positively
with each other and negatively with the rate of reproduc-
tion [54,55]. It makes sense therefore that insulin signal-
ing is also connected to longevity. In Caenorhabditis elegans
mutations of genes involved in insulin/IGF-1 signal trans-
duction lead to extended life span [18,56]. Mutations in
genes homologous to the mammalian insulin/IGF-1
receptor signaling pathway, insulin receptor substrate
homologue chico or insulin like receptor InR gene extend
longevity in Drosophila [18]. In mammals and particularly
humans insulin is certainly connected to longevity, but in
a rather contradictory way. On the one hand insulin resist-
ance is associated with a series of fatal disorders and cen-
tenarians are known to have high insulin sensitivity [18],
but on the other, the Klotho gene whose overexpression is
known to increase lifespan has been shown to act by
increasing insulin resistance [19]. FIRKO mice with fat cell
specific insulin resistance have a prolonged life span [57].
Resveratrol, a plant derived compound that is known to
prolong lifespan in yeast, C. elegans and Drosophila, and
now shown to be active in mammals as well, also acts by
inhibition of insulin signaling pathway [58]. On the con-
trary life extension in dwarf mice is associated with
reduced secretion of insulin and increased hepatic sensi-
tivity to insulin [59]. The key differences in the contradic-
tory results might lie in differential tissue specific
resistance to insulin. Currently the association of insulin
resistance with longevity in humans remains ambiguous.
However there is strong evidence that insulin signaling
and insulin resistance is certainly involved in determining
longevity in widely differing animals. The strong influ-
ence of insulin resistance in reproductive and life history
strategies therefore must have played a major role in the
evolution of insulin resistance.
The "stronger to smarter" or "soldier to diplomat" 
transition
We suggest that insulin resistance mediates a shift from
muscle dependent to brain dependent strategies of mak-
ing a livelihood. This is achieved partly by changing the
relative energy allocation to muscle versus brain and
partly by insulin signaling in the nervous tissue. Insulin
resistance is characterized by reduced glucose uptake by
muscle and viscera resulting into high plasma glucose lev-
els and since the uptake of glucose by brain cells is almost
independent on insulin levels in the physiological range
[60,61], more glucose is available for the brain. Studies
are needed to test whether this extra energy made availa-
ble by insulin resistance positively affects the brain func-
tion, but an alternative mechanism by which brain
function is enhanced has substantial experimental evi-
dence. Insulin resistance is also characterized by hyperin-
sulinemia. Insulin receptors are widely distributed in
specific brain areas including choroids plexus, olfactory
bulb, pyriform cortex, amygdaloid nucleus, hippocam-Page 4 of 13
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insulin receptor in the central nervous system differs both
in structure and function from the peripheral tissue recep-
tor [62]. The brain also synthesizes some amount of insu-
lin, but plasma insulin levels do affect brain functions
substantially. Insulin and insulin receptor in the CNS is
associated with neuronal development [63] as well as a
number of cognitive functions including spatial and ver-
bal memory [62]. Streptozotocin, which inhibits insulin
receptor function causes long term diminution in mem-
ory in rats on intracerebroventricular administration [64].
Insulin signaling plays a significant role in cognitive func-
tions of the brain. Peripheral insulin resistance accompa-
nied by high levels of insulin can therefore be said to be
good for brain function. Two other molecules which, sim-
ilar to insulin, were thought to be important in energy
metabolism alone, and which play a significant role in IRS
are now shown to enhance cognitive functions, namely
leptin [65] and cholesterol [66].
Contrary to the positive effects of raised insulin levels on
brain function, diabetic patients have increased risk of
developing dementia and Alzheimer's disease (AD) [67-
69]. However, these effects are observed only in old age
subjects [70]. Furthermore, it is likely to be a result of local
insulin deficiency rather than sustained high levels of
insulin [71,72], since in AD patients the csf to plasma
insulin ratio is particularly low and negatively related to
the severity of AD [73]. Elevated insulin is shown to
enhance memory in AD patients [74] and intranasal insu-
lin has been advocated as a treatment for AD [75,76]. It is
possible that impairment of insulin receptors at the blood
brain barrier [77] may be central to the adverse effects on
the CNS.
In young and middle age, adverse effects of hyperinsuline-
mia or insulin resistance on brain function are rare [70].
On the contrary, there are positive short term effects. If the
negative effects are at an age well past the reproductive
age, natural selection is unlikely to be affected by them.
On the other hand the positive effects at an early age
would be strongly selected for. Therefore it is a logical
proposition that hyperinsulinemia would have selective
advantages for a brain dependent lifestyle.
Further, high levels of insulin are shown to slow down
pre-attentive responses simultaneously enhancing atten-
tive responses [78]. Research in this direction is limited,
but it raises a possibility that insulin suppresses fast motor
reflexes and enhances relatively slower functions such as
memory and thinking. If this generalization is true it is in
support of our hypothesis. Fast reflexes are typically
required in soldier life and thinking in diplomat life. The
raised plasma insulin levels in insulin resistance may
bring about this subtle transition as well.
It is not surprising that reduced physical activity tends to
induce insulin resistance or type 2 diabetes and that mus-
cle exercise can partly revert insulin resistance [11,79,80].
It is logical to allocate a reduced budget to an organ that
is less active and increase the budget allocation when its
consumption increases. However, there is an additional
possible mechanism through which muscle insulin resist-
ance may be adaptive. Water maze trained mice were
shown to up-regulate insulin signaling in the hippocam-
pus [81]. It is possible therefore that when intense brain
activities are consistently required the body may respond
by making more insulin as well as more insulin receptors
in the CNS. However, since higher plasma insulin levels
result in hypoglycemia and hypoglycemia is detrimental
to brain function, peripheral insulin resistance develops
to maintain higher plasma glucose. Hyperinsulinemia is
known to down-regulate insulin receptor activity in
peripheral tissues but not in the nervous tissue [77] and
this differential loss of sensitivity presumably enhances
brain activity at the cost of muscle activity. According to
the classical belief, insulin resistance is a primary response
and hyperinsulinemia develops as a compensatory
response. We are tempted to suggest that hyperinsuline-
mia to enhance brain function may develop primarily in
people with a sedentary and brain centered life style.
However hyperinsulinemia may result into hypoglycemia
which is detrimental to brain function [82,83] and to pre-
vent this, peripheral insulin resistance develops as a com-
pensatory adaptation.
The soldier to diplomat transition also explains the asso-
ciation of low birth weight with insulin resistance in later
life. Muscle cells do not multiply in adult life and nor do
nerve cells. If nutrient limitation affects intrauterine devel-
opment, brain development is the least affected among all
the organs [84,85]. As a result, if the intrauterine growth
is slow or impaired, muscle weight is poor but the brain is
relatively well developed. For such an individual, facing a
competitive environment in adult life, trying to be smarter
is a better bet than trying to be stronger. The muscle mass
being poor, competing with others in muscle activity is
unlikely to succeed. On the other hand brain develop-
ment being normal, such a person is more likely to com-
pete successfully in brain related activities. An individual
born small for gestational age therefore should take to a
diplomat life rather than a soldier life and insulin resist-
ance is adaptive for such an individual.
If there are no developmental constraints during intrau-
terine or early infant development there need not be a
trade-off between body physique and brain development.
A positive association between IQ and physique has been
shown in twin studies and the causes claimed to be
genetic [86], but intrauterine factors could play a substan-
tial role. However, with developmental constraints suchPage 5 of 13
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and a negative association between physique and IQ is
more likely to develop. Developmental constraints would
affect both brain and physique, but not equally. The brain
sparing effect and priority to brain over muscle becomes
inevitable in these circumstances and we suggest that
insulin resistance is a mechanism by which this shift in
balance during development is maintained in adult life as
well. Adopting a brain centered life need not necessarily
mean having a higher IQ just as people with more muscle
dependent life style such as hunters or laborers are not
necessarily the most highly muscular persons. For devel-
opment compromised individuals, since brain develop-
ment is the least affected, a brain centered life is the best
out of the bad options.
In primate societies individuals start gaining a position in
the social hierarchy among their age group from a very
early age [87-90]. Therefore we expect the childhood
growth rate to be a surrogate of the developing social rank,
and a significant positive correlation between growth rate
and insulin resistance is not surprising [11]. Individuals
born small but growing fast have a triple reason for devel-
oping insulin resistance. On the one hand, owing to
smaller muscle mass they are unlikely to succeed as sol-
diers and have to adapt a diplomat way of living. On the
other hand, the rapidly gained better social ranking would
drive them further towards a K and smarter phenotype for
reasons described below. Small birth weight might also be
taken as a cue to overpopulation and competition for
food, which can be another trigger for adopting K and
smarter strategies. If the three triggers act independently
or additively, there would be a high risk for "born small
grown big" individuals [11].
In an apparently contradictory way predisposing factors to
insulin resistance include both overeating and malnutri-
tion. It is possible to explain both with a coherent logic.
When foraging success is a limiting factor for the fitness of
an individual it is necessary to invest in muscle to enhance
foraging activity. When food is ample, fitness would
depend more on social interactions than on foraging for
any social species. Disinvestment from muscle and
increased investment in brain towards gaining higher
social manipulation skills would be adaptive under these
conditions. On the other hand in extreme malnutrition
and fetal malnutrition in particular, the available nutri-
ents should be preferably diverted to the brain as a mini-
mum survival need. The 'selfish' brain itself actively
manipulates resource allocation under certain conditions
[91]. The mechanisms of preferential allocation to the
brain include insulin resistance. Thus insulin resistance
should be adaptive under both extremes of nourishment.
Why a common switch for two phenotypic transitions?
Although being smarter and being K selected are two inde-
pendent strategies, there is a marked similarity in the
socio-ecological conditions under which a smarter pheno-
type would get selected and those under which a K strate-
gist would get selected. The two transitions are also likely
to interact with each other as schematically shown in fig-
ure 1. Therefore a common switch for both could have
evolved. A high population density is a natural condition
for changing reproductive strategies. High population
density also leads to more intense competition and niche
separation is one of the effective ways to handle competi-
tion. The soldier-diplomat dichotomy can be viewed as a
way of niche separation. Competition also increases the
variance in individual successes, leading to a greater hier-
archy or social divide. This would leave some section of
the society malnourished and some with a greater control
over resources. Chronic malnutrition is also a predispos-
ing factor for insulin resistance, particularly fetal malnu-
trition for reasons explained earlier. In a saturating
environment all individuals would not be equally quick
to adopt a K strategy. A policy of cutting down the number
of offspring can be successful only if the probability of off-
spring survival is sufficiently high. In social organisms the
high-ranking individuals are relatively less risk prone and
have a greater control over resources improving their
chances of survival in crisis. Therefore we expect the high
social rank individuals to preferentially adopt a K strategy.
The high-ranking individuals are also in a better position
to manipulate other individuals in the social group and so
can be more successful as diplomats. Successful diplomats
in turn have greater control over resources and should be
in a better position to ensure offspring survival and so
preferentially adopt a K strategy.
An interesting possibility, although quite speculative at
this stage is that of exaptational overeating and obesity.
Money is a very recent phenomenon in the evolutionary
history of humans and therefore separate brain centers to
handle money related emotions and information process-
ing are unlikely to have evolved. The brain areas involved
in handling food related emotions and information were
presumably exapted to handle money. Therefore there
could be a cross talk between the neural mechanisms of
handling money and food. It's known that the region of
the orbitofrontal cortex involved in processing food
rewards is also involved in processing money rewards [92-
94]. Briers et al showed that under experimentally manip-
ulated situations hunger affects money related decisions
and the desire for money increases hunger [95]. It is also
possible that the desire to accumulate wealth results into
a tendency to store fat. This interesting possibility gener-
ates many key questions and needs a deeper probe. Cur-
rently studies in this direction are limited and we do not
intend to lay more emphasis on it other than stating thatPage 6 of 13
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neuro-physiological processes could interact.
Thus the triggers for the two transitions are not nutritional
alone but social, behavioral, economic and ecological.
The insulin resistance syndrome has traditionally been
viewed as a nutritional disorder. We would like to empha-
size that apart from diet, other factors can also be an
important consideration in management and control of
metabolic disorders. The predisposing factors for IRS are
not only sedentary life and rich diet but also local popula-
tion density, competitive social environment, strong eco-
nomic motives, social divide, social manipulation skills
and the tendency to avoid physical aggression.
Why an association between obesity and insulin resistance?
Adipocytes have a crucial role in IRS. Obesity is a prime
risk factor for diabetes and related disorders. There are a
number of possible reasons compatible to our hypothesis
for an association between adiposity and insulin resist-
ance.
1. The brain consists of 60–70% fat by dry weight and
lipid metabolism is shown to affect brain development,
intelligence, and behavior [96-100]. Insulin signaling is
suspected to play a role in myelination of nerve fibers [77]
and myelin sheaths are predominantly composed of fat.
Fat storage can be viewed as a raw material buffer in brain
development and function.
2. Fat accumulation can be a cue for high social ranking in
traditional human societies and high social ranking is a
prerequisite for transition to K selection.
3. Adiposity can work as a social signal. The theory of hon-
est signaling or the "handicap principle" emphasizes the
Causal relationships between environmental factors and the two transitionsFigure 1
Causal relationships between environmental factors and the two transitions. Thick arrows indicate causations for 
which there is adequate evidence currently. Thin arrows are the causations suggested by our hypothesis that need to be 
tested.
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intensions and that signals with high cost are more honest
[101]. A smarter individual would avoid physical aggres-
sion and gain fitness by manipulating other individuals.
In order to avoid physical fights an honest signal has to be
passed on to other individuals. A change in body propor-
tions (central obesity) can be a fast and efficient signal
since peripheral fat is more difficult to differentiate from
muscularity than abdominal fat. It makes sense therefore
that central obesity is more strongly correlated with insu-
lin resistance than peripheral fat (2,7). Fat storage has a
high energy cost making it a more honest signal.
4. Obesity adversely affects agility which is an important
requirement of soldier life. An obese individual is unlikely
to be a successful soldier and therefore would find a dip-
lomat transition more adaptive.
The origins of pathology
We have argued throughout that insulin resistance is an
adaptive response. Furthermore at least under certain con-
ditions insulin resistance can actually increase the life
span [19]. On this background, we need to answer the
question, why a tendency that was adaptive, has turned
into a pandemic disorder today. We feel that the patho-
logical effects are caused by supernormal stimuli. All the
stimuli for development of either or both the phenotypic
transitions such as population density, social competitive-
ness, economic motives, social inequality, sedentary life
and rich diet have reached unprecedented levels today to
which the body gives an exaggerated response leading to
pathological effects.
Of particular interest are the immunological changes
accompanying obesity and insulin resistance. We suggest
that the distribution of the immune system within the
body changes with the behavioral strategies of an individ-
ual. It has been suggested that the apparent immunosu-
pression accompanying high testosterone levels is not a
"suppression" of the entire immune system but a redistri-
bution of it [102]. Since high testosterone levels are asso-
ciated with male aggression, components of the immune
system migrate to the subcutaneous tissues anticipating
fights and injuries. In a soldier to diplomat transition we
expect a redistribution response in the reverse direction in
which components of the immune system are withdrawn
from the subcutaneous tissues as physical fights are less
likely. This can result into increased sensitivity to inflam-
mation in the central tissues and a delay in cutaneous
wound healing. An exaggerated redistribution response in
this direction may make the central tissues more inflam-
mation prone. Inflammatory changes are increasingly
being recognized as a major contributor to the comorbid-
ities of the metabolic syndrome. Anti-inflammatory drugs
can reverse at least some of the components of the insulin
resistance syndrome [103,104]. Atherosclerosis involves
inflammation of the vascular epithelium [105-108]. Adi-
pocytes produce many signal molecules including IL-6,
TNF alpha and C reactive protein that enhance inflamma-
tory response. Concentrations of these immune markers
are positively correlated to measures of total and particu-
larly central obesity [109]. Chronic inflammation is sus-
pected to be the main mechanism of adiposity induced
insulin resistance, fatty liver disease, airway inflammation
and atherosclerosis [110-113].
There is evidence that loss of pancreatic beta cell function
that underlies clinical diabetes is also induced by inflam-
mation. Glitazones that have been used in the treatment
of type 2 diabetes act as PPAR-gamma agonists. On bind-
ing with them PPAR-gamma forms a heterodimer that can
interfere with proinflammatory pathways [114]. The ben-
eficial effects of glitazones are likely to be via reduction in
inflammation of the pancreas itself. The clinical onset of
type 2 diabetes therefore may be a result of immune redis-
tribution accompanying the soldier to diplomat transi-
tion. It is possible that some of the inflammatory
reactions are actually triggered by subclinical infections.
Mild infections can be the precipitating cause of morbid
disorders but the root cause is likely to be the exaggerated
immune redistribution response of the body.
The immune redistribution hypothesis is also supported
by the negative association between testosterone levels
and insulin resistance in males [38,39,115-122]. Rise in
testosterone levels may reverse insulin resistance
[118,120]. While testosterone is suggested to drive the
immune system subcutaneous, insulin resistance accord-
ing to our hypothesis, does the reverse.
It is very likely that primary and limited insulin resistance
in which loss of peripheral sensitivity and raised insulin
levels compensate each other can be good for health and
longevity. Klotho gene induced insulin resistance is
shown to increase longevity [19,123] but lipo-apoptosis,
inflammatory changes and beta cell defects are the con-
founding factors leading to the cluster of diseases. It is
likely therefore that controlling obesity and immunologi-
cal changes would be a more effective therapeutic strategy
than trying to reduce insulin resistance. A serious thought
and thorough examination of this proposition is needed
since, if proved to be correct, it can change the line of
treatment of metabolic disorders substantially.
Social hierarchy and insulin resistance
There is a positive correlation between obesity and insulin
resistance in all the ethnic groups examined
[2,7,29,80,124], and central obesity is even better corre-
lated [7,124]. Obesity alone, however, does not explain
the higher prevalence in higher income groups in tropicalPage 8 of 13
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type 2 diabetes with income remained significant even
after accounting for age and obesity [125,126], suggesting
that social hierarchy may play a role independent of the
nutritional status.
In an interesting experiment a Wistar rat colony exposed
to chronic malnutrition was compared with a control col-
ony [127]. The control colony was fed ad libitum and the
malnourished colony was fed a limited diet only once a
day. In effect the malnourished animals ate approximately
50 % in amount as compared to the control. The control
colony diet was also higher in protein and fat. The mal-
nourished animals showed exceedingly high levels of
insulin than the control ones. In the malnourished indi-
viduals, the mean body weight was reduced but the brain
weight was preserved. Remarkably, the malnourished ani-
mals accumulated disproportionately more fat than the
control ones. Across the two groups there was a negative
association between body weight and hyperinsulinaemia,
but within the malnourished group there was a positive
correlation. Among the malnourished group, animals
with higher BMI were severely insulin resistant although
their BMI were substantially lower than the control group
with normal diet and whose insulin and glucose levels
were normal. This suggests that relative obesity rather
than absolute one played a major role. These apparently
contradictory effects of body weight on insulin levels can
best be explained by the K strategy hypothesis. Malnutri-
tion is a cue to a saturating population, which is the
appropriate time to adopt a K strategy. However within
the malnourished, the heavier and so presumably high
social ranking individuals should preferentially take to
this strategy. The incidence of diabetes today is rapidly
increasing in the third world countries and the affluent in
these countries are at maximum risk [80,128-130], a pic-
ture that matches well with the rodent experiment [127].
There are other reasons to believe that, relative, rather
than absolute, nutritional status is more important. Food
rationing which reduces nutritional variance has resulted
in a dramatic reduction in diabetes on a number of occa-
sions [131]. In a number of studies, the prevalence of type
2 diabetes in urban areas was significantly more than rural
ones [80,128-130]. In all these studies, obesity was more
prevalent in the urban communities. However the regres-
sion coefficients of insulin resistance parameters with
obesity parameters were higher in rural areas [129,130]
although the intercept was substantially smaller. It is pos-
sible that the lower intercept was due to low population
densities and more physical work in the rural areas. But
the higher slope suggests that although rural communities
were much less obese as compared to their urban counter-
parts, the relatively more obese individuals within the
rural community were more prone to the disorder [11].
This suggests that relative, rather than absolute obesity
matters. The thriftiness hypotheses are unable to explain
the importance of relative obesity.
Contradicting this picture is the reversal of socioeconomic
correlates of metabolic disorders in developed countries.
Contrary to tropical Asia the correlation between socioe-
conomic status and metabolic disorders is negative in
many developed countries [132-136]. We need a careful
look at these data to see whether the trend remains after
correcting for race, diet, smoking and other risk factors.
Alley et al [137] show that the proportion of whites and
non-whites was substantially different across socioeco-
nomic groups. Racial differences may partly explain the
negative socioeconomic trend. Contrary to the expecta-
tion of the feast and famine hypothesis ethnic groups of
tropical origin appear to have a greater tendency to
develop insulin resistance as compared to people from
harsh winter areas [30-36]. In harsh winter habitats, hunt-
ing-gathering or agriculture was possible only for a few
months of the year and during winter people were forced
to take an indoor sedentary life and survive on stored
food. Sedentary life is a known predisposing factor for
metabolic disorders. We suggest that the forced seasonal
sedentary life for several generations could have selected
against the genes predisposing for metabolic syndrome in
response to sedentary life. Therefore the obesity threshold
for IRS in these people is higher than the tropical people
who could remain active hunter-gatherers throughout the
year and for whom sedentary life is only a modern phe-
nomenon. Studies in which racial factors are adequately
incorporated show a much weaker negative socioeco-
nomic trend [138-140]. It is likely that since in the devel-
oped world even the relatively deprived class is not
malnourished, and owing to mechanization most of the
labor class also does little physical work, differences in
nutrition and exercise are not similar to the less developed
societies. Therefore other factors such as crowded living
conditions may become important. Traditionally high fat
diet is associated with high social ranking. However, in
these societies the lower classes consume more fat and
that could be the major confounding factor.
Testing the hypothesis
Apart from being able to explain most of the known epi-
demiological patterns the hypothesis makes many more
predictions that are potentially testable.
(i) Comparison across animal species: If insulin resistance
is a social adaptation, more social species should show a
greater tendency to develop insulin resistance. If, on the
other hand, it is a thrifty adaptation, species evolved in
highly seasonal environments, species that hibernate or
migrate long distances and store substantial amounts of
fat before hibernation or migration should show the high-Page 9 of 13
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across species is difficult and there are no data for sound
interspecies correlation currently. However, in the long
run, a careful multispecies comparison can be enlighten-
ing in many ways.
ii) The fetal origins or thrifty phenotype hypothesis pre-
dicts that although a transition from traditional lifestyle
to the urban western lifestyle is associated with a high
prevalence of IRS, it will quickly reduce in subsequent
generations as the birth weights improve [5]. Although
the social adaptation hypothesis incorporates the effect of
low birth weight, it predicts that improvement in birth
weights alone will not wipe off the difference completely.
iii) According to the K selection hypothesis the incidence
of insulin resistance should correlate positively with local
population density after correcting for other risk factors.
There is some evidence that obesity and type 2 diabetes
are more prevalent in crowded cities but it hasn't been
interpreted as an effect of crowding [141-143].
iv) Since the relative position in the social hierarchy is
important it is possible that the prevalence of IRS could be
low in nutritionally egalitarian societies. Societies with a
greater rich-poor divide, particularly in the nutritional
quality, should show a higher incidence.
v) The parental investment theory predicts certain gender
differences in reproductive behavior [144]. The reproduc-
tive success of males can increase to a much greater extent
with increase in inputs as compared to females. This is
because high ranking males can gain access to more
females and thus raise their total reproductive success. A
corollary is that few other males will be left with little
reproductive opportunities. The reproductive success of
females on the other hand has limited variance. As a result
investments in male and female offspring pay in different
ways. If the increased fetal weight in gestational insulin
resistance is an investment strategy, we expect a difference
in male and female fetuses. Insulin resistant mothers
should invest more in male than in female fetuses. As a
result the relation between maternal insulin resistance
and birth weight should be stronger and steeper for male
than for female infants.
There are many sources of confusion and contradiction in
our current understanding, the major one being about
longevity versus fatality and adaptive versus pathological
course. The key area on which more research inputs are
needed is the differential effects of insulin resistance in
different tissues. Tissue specific gene expression or knock
out studies have already started contributing to our under-
standing. Apparently fat cell specific insulin resistance is
"good" for health and longevity and hepatic and brain
insulin resistance is "bad". The key question is that
whether different triggers for insulin resistance affect dif-
ferent tissues in different ways. We need to know whether
clinical progression of insulin resistance serially impairs
the sensitivity in fat cells, muscle, liver, blood brain bar-
rier and ultimately the brain. It is tempting to suggest that
the former two may actually be good for health and the
latter bad. Answering these questions could revolutionize
the way of thinking with respect to the basic biology as
well as clinical management.
Implications of the hypothesis
The traditional view that insulin resistance evolved as a
mechanism to combat periodic starvation is grossly inad-
equate and other interpretations of the phenomenon are
possible. There is strong evidence that insulin resistance
changes the reproductive and life history strategies on the
one hand and life sustenance strategies on the other.
Therefore insulin resistance is more likely to have evolved
as a switch in reproductive and sustenance strategies than
energy homeostasis alone. The pathological consequences
of the syndrome are likely to be caused by the immune
redistribution response rather than insulin resistance per
se. If the hypothesis stands the tests, it can change the epi-
demiological thought and help us refine the line of action
for control of the disorders associated with the Insulin
Resistance Syndrome. Clearly substantial research inputs
are needed to bring about a change in paradigm, but a
possible change in the line of control and treatment poli-
cies can be perceived today. Since the insulin resistance
syndrome is a major cause of morbidity and death
throughout the world today, and since an evolutionary
understanding has the potential to revolutionize the line
of prevention and treatment of the disorder it would be a
valuable example of contribution of evolutionary biology
to medicine.
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